ND BT3814
Alternative Names: ND-BT3814Latest Information Update: 12 Oct 2022
At a glance
- Originator BioArctic
- Class Antibodies
- Mechanism of Action TDP-43 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Amyotrophic lateral sclerosis
Most Recent Events
- 23 Sep 2022 Early research in Amyotrophic lateral sclerosis in Sweden, prior to September 2022 (BioArctic pipeline, September 2022)